Enlivex Therapeutics Ltd (ENLV)

Currency in ILS
393
-20(-4.82%)
Closed·
ENLV Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ENLV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
388414
52 wk Range
309629
Key Statistics
Bid/Ask
393.00 / 394.00
Prev. Close
413
Open
393
Day's Range
388-414
52 wk Range
309-629
Volume
19.43K
Average Volume (3m)
23.85K
1-Year Change
-17.81%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ENLV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Enlivex Therapeutics Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Enlivex Therapeutics Ltd Company Profile

Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra (ENX-CL-02-002), which is in phase II clinical trial for the treatment of organ dysfunction and failure caused by sepsis; and Allocetra (ENX-CL-05-001), which is in phase I/II clinical trial to treat moderate knee osteoarthritis. The company also develops 0189-22-KMC, which is in phase I/II clinical trial to treat end-stage knee osteoarthritis; 0006-24-KMC, which is in phase I/II clinical trial for the treatment of Basal thumb osteoarthritis; and ENX-CL-06-001 to treat Psoriatic arthritis and is in phase I/II clinical trial. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Ness Ziona, Israel.

Compare ENLV to Peers and Sector

Metrics to compare
ENLV
Peers
Sector
Relationship
P/E Ratio
−2.0x−3.8x−0.5x
PEG Ratio
−0.04−0.030.00
Price/Book
1.4x2.4x2.6x
Price / LTM Sales
-9.9x3.2x
Upside (Analyst Target)
-422.1%42.7%
Fair Value Upside
Unlock3.7%5.8%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-0.15 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ENLV Income Statement

People Also Watch

53,410
NICE
+1.37%
32,040
RMLI
+0.22%
1,279.0
ELAL
+1.19%
5,555
TEVA
+1.83%
1,617.0
NWMDp
+0.87%

FAQ

What Stock Exchange Does Enlivex Trade On?

Enlivex is listed and trades on the Tel Aviv Stock Exchange stock exchange.

What Is the Stock Symbol for Enlivex?

The stock symbol for Enlivex is "ENLV."

What Is the Enlivex Market Cap?

As of today, Enlivex market cap is 94.05M.

What Is Enlivex's Earnings Per Share (TTM)?

The Enlivex EPS (TTM) is -0.66.

From a Technical Analysis Perspective, Is ENLV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Enlivex Stock Split?

Enlivex has split 0 times.

How Many Employees Does Enlivex Have?

Enlivex has 0 employees.

What is the current trading status of Enlivex (ENLV)?

As of 23 Jul 2025, Enlivex (ENLV) is trading at a price of 393.00, with a previous close of 413.00. The stock has fluctuated within a day range of 388.00 to 414.00, while its 52-week range spans from 309.00 to 629.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.